Global Halitosis Market Size (2024 - 2029)

The halitosis market is anticipated to experience significant growth, driven by factors such as the rising prevalence of periodontal diseases, increased consumption of alcohol and tobacco, and medical conditions like tonsillitis and sinus inflammation. The COVID-19 pandemic has also highlighted the importance of diagnosing and treating halitosis, contributing to market expansion. Despite these growth drivers, challenges such as a lack of awareness about halitosis and its treatments, along with the availability of alternative therapies, may impede market progress.

Market Size of Global Halitosis Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Halitosis Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 12.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Global Halitosis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Halitosis Market Analysis

The halitosis market is projected to register a CAGR of 12.5% over the forecast period (2022 - 2027).

As with other circulating pandemics, halitosis has been greatly challenged by the outbreak of the coronavirus disease (COVID-19), and a few confirmed cases have been reported to be present with halitosis while being actively infected. For instance, the article titled "Oral manifestations in mild-to-moderate cases of COVID-19 viral infection in the adult population" published in the National Library of Medicine in March 2021 stated that halitosis was prevalent in 10.5% of the patients that were included in the survey. A total of 573 COVID-19 individuals were included in the survey, which intended to highlight the oral manifestations that could be seen in mild-to-moderate cases of the disease. The study found that oral symptoms are related to mild-to-moderate cases of COVID-19 infection, and individuals with infectious diseases should have regular dental examinations. Such studies have highlighted the diagnosis and treatment of halitosis amid the pandemic phase, which is in turn expected to boost the market's growth over the coming years.

Furthermore, the factors propelling the growth of the market are the rising prevalence of periodontal diseases; increasing consumption of alcohol and tobacco; medical conditions such as tonsils; and inflammation of the nose, throat, or sinuses. As per the study titled "The Prevalence and Determinant Factors of Oral Halitosis in Northwest Ethiopia: A Cross-Sectional Study" published by Dovepress in 2021, halitosis is reported to be the third most common reason for visiting a dentist, trailing only dental caries and periodontal disease. The prevalence of halitosis among adults worldwide ranged from 22% to 50%. Moreover, as per another article titled "Say Ahhh: Experience and Views on Halitosis Management in the General Public in Victoria, Australia" published in August 2021 by the International Dental Journal, up to 90% of cases of halitosis are caused by intraoral sources, such as tongue coating or periodontitis, while 8% to 10% are due to extraoral factors. When a patient is devoid of intraoral causes of halitosis, it may be a sign of systemic, metabolic, or hereditary illnesses. Thus, the increasing prevalence of halitosis globally is a major factor that is expected to drive the diagnosis and treatment of halitosis in the near future.

Furthermore, persistent bad breath or a bad taste in the mouth may be a warning sign of gum (periodontal) disease, which is closely associated with halitosis. As per an article titled "Periodontal Disease Prevalence, Extent, and Risk Associations in Untreated Individuals" published in January 2022 by the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP), the prevalence of total periodontitis and stage III/IV periodontitis was 85.4% and 48.5%, respectively. The prevalence of CDC/AAP moderate-severe and severe periodontitis was 78.4% and 31.1%, respectively. Therefore, the increasing prevalence of periodontal diseases is expected to drive market growth over the analysis period.

However, a lack of awareness about halitosis and its treatment and the availability of alternative treatments are expected to hamper the market's growth during the forecast period.

Halitosis Industry Segmentation

As per the scope of this report, halitosis is an oral health problem where the main symptom is bad-smelling breath. In most cases, finding the cause of the bad breath is the first step toward treating this preventable condition. The Halitosis Market is segmented by Types (Pathological and Non-pathological), By Treatment (Antacids, Antiseptics, Antiplaque, and Others), By Diagnostic Test (Halimeter, Gas chromatography, BANA test, β-galactosidase activity assay, Other Tests), By Indication (Respiratory Disorders, Liver Disorders, Gastrointestinal Disorders, Kidney Disorders, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally.

By Type
Pathological
Non-pathological
By Treatment
Antacids
Antiseptics
Antiplaque
Others
By Diagnostic Test
Halimeter
Gas chromatography
BANA test
β-galactosidase activity assay
Other Tests
By Indication
Respiratory Disorders
Liver Disorders
Gestrointestinal Disorders
Kidney Disorders
Others
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Halitosis Market Size Summary

The halitosis market is experiencing significant growth, driven by various factors including the rising prevalence of periodontal diseases, increased consumption of alcohol and tobacco, and medical conditions such as tonsillitis and sinus inflammation. The COVID-19 pandemic has also played a role in highlighting the importance of oral health, as studies have shown a correlation between the virus and halitosis. This has led to a greater emphasis on diagnosis and treatment, further propelling market expansion. The market is characterized by a competitive landscape with major players like Dabur India, Colgate Palmolive, and Johnson & Johnson leading the charge. These companies are actively launching new products to cater to the growing demand for effective halitosis solutions.

The North American region is a significant contributor to the halitosis market, attributed to increased awareness, availability of treatments, and a high prevalence of periodontal diseases. The market is also influenced by the rising incidence of liver disorders, which are associated with specific types of bad breath, such as Fetor hepaticus. Despite the challenges posed by a lack of awareness and alternative treatments, the market is poised for growth, supported by ongoing product innovations and strategic acquisitions by key players. The forecast period is expected to see continued expansion, driven by both intraoral and extraoral factors contributing to halitosis.

Explore More

Global Halitosis Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Periodontal Diseases

      2. 1.2.2 Availability of Wide Range of Products

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Awareness About Halitosis and its Treatment

      2. 1.3.2 Alternative Treatment

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 Pathological

      2. 2.1.2 Non-pathological

    2. 2.2 By Treatment

      1. 2.2.1 Antacids

      2. 2.2.2 Antiseptics

      3. 2.2.3 Antiplaque

      4. 2.2.4 Others

    3. 2.3 By Diagnostic Test

      1. 2.3.1 Halimeter

      2. 2.3.2 Gas chromatography

      3. 2.3.3 BANA test

      4. 2.3.4 β-galactosidase activity assay

      5. 2.3.5 Other Tests

    4. 2.4 By Indication

      1. 2.4.1 Respiratory Disorders

      2. 2.4.2 Liver Disorders

      3. 2.4.3 Gestrointestinal Disorders

      4. 2.4.4 Kidney Disorders

      5. 2.4.5 Others

    5. 2.5 By Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle-East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle-East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Global Halitosis Market Size FAQs

The Global Halitosis Market is projected to register a CAGR of 12.5% during the forecast period (2024-2029)

Dabur India, Colgate Palmolive, Johnson & Johnson, P&G and Oracare are the major companies operating in the Global Halitosis Market.

Halitosis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)